Ranbaxy Laboratories has placed a net loss of Rs464.58 cr

Ranbaxy Laboratories has placed a net loss of Rs464.58 cr for the qtr closed Sept 30, 2011 when compared to net gain of Rs307.94 cr for the qtr closed Sept 30, 2010.

The total revenue of the group surged by 8.71percent to Rs2197.56 cr for the qtr closed Sept 30, 2011 from Rs2021.58 cr for the qtr closed Sept 30, 2010.

Be Sociable, Share!
Tags:

Stock Market Basics For Beginners

Secondary Market?

Secondary Market? Secondary Markets refers to a market where securities are traded after being initially offered to the public (IPO) in the primary market, Secondary market comprises ...…

Term Derivative

Term Derivative Derivative is usually a product whose worth hails from the value of more than one basic factors, known as underlying. The underlying property can be ...…

What is Support And Resistance?

What is Support And Resistance? One of several interesting phenomena of share markets that are usually catchy is a activity of share prices at the blink of eyes. At one ...…

American Depositary Receipt

American Depositary Receipt American Depositary Receipt (ADR) is known as a negotiable certificate¬† issued by an american bank stating that a number of stocks in the overseas firm ...…

Term Debt Instrument

Term Debt Instrument Debt instrument shows an agreement by which one party gives cash to another on pre-determined conditions with regards to rate as well as periodicity of ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics